Treatments against Polymorphosal discrepancies in Glioblastoma Multiform

dc.contributor.authorMukerjee, Nobendu
dc.contributor.authorMaitra, Swastika
dc.contributor.authorRoy, Subhradeep
dc.date.accessioned2024-06-06T07:18:26Z
dc.date.available2024-06-06T07:18:26Z
dc.date.issued2022-09
dc.description.abstractGlioblastoma (GB) are aggressive tumors that obstruct normal brain function. While the skull cannot expand in response to cancer growth, the growing pressure in the brain is generally the first sign. It can produce more frequent headaches, unexplained nausea or vomiting, blurred peripheral vision, double vision, a loss of feeling or movement in an arm or leg, and difficulty speaking and concentrating; all depend on the tumor's location. GB can also cause vascular thrombi, damaging endothelial cells and leading to red blood cell leakage. Latest studies have revealed the role of single nucleotide polymorphisms (SNPs) in developing and spreading cancers such as GB and breast cancer. Many discovered SNPs are associated with GB, particularly in great abundance in the promoter region, creating polygenetic vulnerability to glioma. This study aims to compile a list of some of the most frequent and significant SNPs implicated with GB formation and proliferation.
dc.identifier.otherhttp://dspace.daffodilvarsity.edu.bd:8080/handle/123456789/12657
dc.identifier.urihttp://dspace.daffodilvarsity.edu.bd:8080/handle/123456789/12657
dc.language.isoen_US
dc.publisherDaffodil International University
dc.sourceDIU Institutional Repository
dc.subjectEpidermal growth factors receptor
dc.subjectGlioblastoma
dc.subjectSingle nucleotide
dc.subjectpolymorphisms
dc.subjectTumors
dc.titleTreatments against Polymorphosal discrepancies in Glioblastoma Multiform
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Treatments against Polymorphosal discrepancies in Glioblastoma Multiform.docx
Size:
12.95 KB
Format:
Adobe Portable Document Format

Collections